GlassScriptPhysician profile
Jamie R Litvack
NPI 1487809703
$4,964.37
in general payments reported to CMS, 2019-2025
14 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $416 · 2021: $194 · 2022: $59.90 · 2023: $1,323 · 2024: $1,796 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713 · Travel and Lodging: $1,566 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.81 |
| Travel and Lodging | $1,565.63 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,670.23 | 2021-2024 | |
| Medtronic, INC. | $1,610.24 | 2022-2025 | Stealthstation S8 Platform, Nuvent, Propel |
| Medtronic USA, INC. | $368.70 | 2019-2020 | |
| Intersect Ent, INC. | $359.31 | 2019-2020 | |
| Arrinex, INC. | $252.33 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $216.57 | 2024-2025 | Dupixent |
| Nico Corporation | $184.70 | 2020 | |
| Integra Lifesciences Corporation | $122.52 | 2019 | |
| Stryker Corporation | $46.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.39 | 2021 | |
| Cook Medical LLC | $37.24 | 2022 | |
| Genzyme Corporation | $25.59 | 2023 | |
| Acclarent, INC | $18.00 | 2023 | Acclarent Aera |
| Eisai INC. | $15.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Litvack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.